All Clinical Trials

Clinical Trial

AHOD1331, A Randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents

  • Recruiting participants (Starts May. 1, 2015)
  • Not accepting healthy volunteers
  • UTSW Principal Investigator: Martha Marie Pacheco

summary

See protocol/CiRB application

eligibility

See protocol/CIRB Application

If you are interested in this clinical trial, please contact AMANDA RICHARDS on the Children’s Health Research Team.Call 214-456-6300Email